gallbladder issues with semaglutide Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Gallbladder and Ozempic: Risks, Symptoms
Description
"I lost my period for about 3 months after I got on 1.0 dose
Earlier this year, the company began selling a generic version of Novo Nordisk's diabetes drug liraglutide
The following categories of proof often decide whether a claim moves forward: 1
The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)
